======= SLC9B2 =======
== Gene Information ==
* **Official Symbol**: SLC9B2
* **Official Name**: solute carrier family 9 member B2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=133308|133308]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q86UD5|Q86UD5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SLC9B2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC9B2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/611789|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Na(+)/H(+) antiporter that extrudes Na(+) or Li(+) in exchange for external protons across the membrane (PubMed:18000046, PubMed:28154142, PubMed:22948142, PubMed:18508966). Contributes to the regulation of intracellular pH, sodium homeostasis, and cell volume. Plays an important role for insulin secretion and clathrin-mediated endocytosis in beta- cells (By similarity). Involved in sperm motility and fertility (By similarity). It is controversial whether SLC9B2 plays a role in osteoclast differentiation or not (By similarity). {ECO:0000250|UniProtKB:Q5BKR2, ECO:0000269|PubMed:18000046, ECO:0000269|PubMed:18508966, ECO:0000269|PubMed:22948142, ECO:0000269|PubMed:28154142}.
|Na H Exchanger|
|monovalent cation:proton antiporter activity|
|lithium:proton antiporter activity|
|positive regulation of osteoclast development|
|positive regulation of bone development|
|regulation of osteoclast development|
|sodium:proton antiporter activity|
|sperm principal piece|
|regulation of bone development|
|clathrin-dependent endocytosis|
|positive regulation of osteoclast differentiation|
|positive regulation of myeloid leukocyte differentiation|
|regulation of insulin secretion involved in cellular response to glucose stimulus|
|regulation of osteoclast differentiation|
|synaptic vesicle membrane|
|sperm motility|
|flagellated sperm motility|
|sodium ion transmembrane transport|
|positive regulation of myeloid cell differentiation|
|cilium or flagellum-dependent cell motility|
|cilium-dependent cell motility|
|mitochondrial membrane|
|regulation of myeloid leukocyte differentiation|
|proton transmembrane transport|
|positive regulation of leukocyte differentiation|
|sodium ion transport|
|regulation of insulin secretion|
|positive regulation of hemopoiesis|
|basolateral plasma membrane|
|regulation of peptide hormone secretion|
|endosome membrane|
|regulation of myeloid cell differentiation|
|receptor-mediated endocytosis|
|regulation of hormone secretion|
|regulation of leukocyte differentiation|
|apical plasma membrane|
|mitochondrial inner membrane|
|monovalent inorganic cation transport|
|regulation of hemopoiesis|
|regulation of protein secretion|
|regulation of peptide secretion|
|regulation of hormone levels|
|positive regulation of cell development|
|cell junction|
|endocytosis|
|inorganic cation transmembrane transport|
|cation transmembrane transport|
|metal ion transport|
|inorganic ion transmembrane transport|
|import into cell|
|regulation of protein transport|
|regulation of peptide transport|
|regulation of establishment of protein localization|
|regulation of secretion by cell|
|regulation of secretion|
|cation transport|
|regulation of cellular localization|
|regulation of cell development|
|ion transmembrane transport|
|positive regulation of cell differentiation|
|regulation of protein localization|
|identical protein binding|
|localization of cell|
|cell motility|
|positive regulation of immune system process|
|transmembrane transport|
|locomotion|
|positive regulation of developmental process|
|ion transport|
|reproductive process|
|reproduction|
|movement of cell or subcellular component|
|regulation of immune system process|
|positive regulation of multicellular organismal process|
|regulation of cell differentiation|
|regulation of transport|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.82|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10367
* **Expression level (log2 read counts)**: 4.87
{{:chemogenomics:nalm6 dist.png?nolink |}}